In-silico study of potential antiviral drug compounds against EGFR kinase domain to target non-small cell lung cancer (NSCLC)
Crossref DOI link: https://doi.org/10.30574/gscbps.2022.21.1.0383
Published Online: 2022-10-30
Update policy: https://doi.org/10.30574/gscbps.ourcrossmarkpolicy
Yakubu Magaji Yuguda,
Disha Mitra,
Yash Datta Kale,
Ankita Pati,
Mhimma Negi,
Syed Moin Uddin,
Minerva L Daya,
Emir Šeherčehajić,
Jyoti B. Marigoudar,
Shivam Kumar,
